ICICI Securities has initiated coverage on Symbiotec Pharmalab with a BUY rating and a Conviction Pick tag, setting a 12-month target of Rs 1,540 against a current price of Rs 1,200 — about 28 perc

Motilal Oswal reiterated a "Buy" rating for Biocon with a price target of Rs520. The target has been revised but positive view on the stock remains intact.

Deven Choksey Research has issued an ACCUMULATE rating on Cipla Ltd, setting a target price of Rs 1,589 against a current market price of Rs 1,432 — an implied upside of 11%.

Geojit Investments Limited has maintained a BUY rating on Strides Pharma Science Ltd.

ICICI Securities has maintained its HOLD rating on Torrent Pharma, nudging up its 12-month target price to Rs 4,800 from Rs 4,600 earlier — a modest 4% upside from

Geojit Financial Services has reiterated an ACCUMULATE rating on Mankind Pharma Limited with a revised 12-month target price of Rs.